Haemonetics Corp logo

Haemonetics Corp

$ 83.56 -0.57 (-0.68%) 10:08 PM EST
P/E:
50.34
P/B:
5.80
Market Cap:
$ 4.23B
Enterprise V:
$ 4.81B
Volume:
106.89K
Avg Vol (2M):
433.79K
Also Trade In:
Volume:
106.89K
Market Cap $:
4.23B
PE Ratio:
50.34
Avg Vol (2-Month):
433.79K
Enterprise Value $:
4.81B
PB Ratio:
5.80
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Name Current Vs Industry Vs History
Cash-To-Debt 0.3
Equity-to-Asset 0.39
Debt-to-Equity 1.12
Debt-to-EBITDA 3.6
Interest Coverage 6.95
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.49
Distress
Grey
Safe
Beneish M-Score -2.8
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 67.87
9-Day RSI 61.1
14-Day RSI 58.65
6-1 Month Momentum % 31.58
12-1 Month Momentum % 48.78

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.73
Quick Ratio 1.76
Cash Ratio 0.92
Days Inventory 208.65
Days Sales Outstanding 52.11
Days Payable 39.31

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1

Financials (Next Earnings Date:2023-02-08 Est.)

HAE's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:HAE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,083.714
EPS (TTM) ($) 1.66
Beta 0.33
Volatility % 51.72
14-Day RSI 58.65
14-Day ATR ($) 2.508516
20-Day SMA ($) 81.576
12-1 Month Momentum % 48.78
52-Week Range ($) 43.5 - 86.48
Shares Outstanding (Mil) 50.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Haemonetics Corp Filings

Document Form Filing Date
No Filing Data

Haemonetics Corp Analysis

Share your research

Headlines

See More
No news.